Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma
1 other identifier
interventional
108
1 country
1
Brief Summary
The purpose of this study is to compare the adequacy of unilateral endoscopic biliary drainage using metallic stent with plastic stent in unresectable, complex, hilar, cholangiocarcinoma and cost analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Nov 2007
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 21, 2008
CompletedFirst Posted
Study publicly available on registry
July 23, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedResults Posted
Study results publicly available
December 23, 2011
CompletedDecember 23, 2011
November 1, 2011
2.4 years
July 21, 2008
August 23, 2011
November 21, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(ITT Analysis)
Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively in each patient.
at 2 weeks and 4 weeks after stent insertion
Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(Per Protocol Analysis)
Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively.
at 2 weeks and 4 weeks after stent insertion
Secondary Outcomes (2)
Patients Survival Times
until patient died or 6 months after the last patient was enrolled
Cost Effective Ratio of Metallic and Plastic Stent
until the patients expire (Markov model)
Study Arms (2)
SEMS
EXPERIMENTALself-expandable metal stent group
PS
ACTIVE COMPARATORplastic stent group
Interventions
metallic stent was inserted into right or left hepatic duct which was planed before intervention using CT scan or MRCP
plastic stent was inserted into right or left hepatic duct which was planed before intervention using CT scan or MRCP
Eligibility Criteria
You may qualify if:
- Unresectable complex hilar cholangiocarcinoma which diagnosis and staging based on computed tomography(CT) or magnetic resonance cholangiopancreatography (MRCP)
You may not qualify if:
- Patients with ASA 4 or 5
- Patients with liver failure.
- Patients unable to comply with follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Srinagarind Hospital. KhonKaen University.
Muang, KhonKaen, 40002, Thailand
Related Publications (4)
De Palma GD, Pezzullo A, Rega M, Persico M, Patrone F, Mastantuono L, Persico G. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc. 2003 Jul;58(1):50-3. doi: 10.1067/mge.2003.310.
PMID: 12838220BACKGROUNDWagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy. 1993 Mar;25(3):213-8. doi: 10.1055/s-2007-1010295.
PMID: 7686100BACKGROUNDFreeman ML, Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc. 2003 Jul;58(1):41-9. doi: 10.1067/mge.2003.292.
PMID: 12838219BACKGROUNDSangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K, Mairiang P. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc. 2012 Jul;76(1):93-9. doi: 10.1016/j.gie.2012.02.048. Epub 2012 May 15.
PMID: 22595446DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Assist. Prof. Apichat Sangchan
- Organization
- Khon Kaen University
Study Officials
- PRINCIPAL INVESTIGATOR
apichat sangchan, MD
Department of Medicine. Faculty of Medicine. KhonKaen University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof.
Study Record Dates
First Submitted
July 21, 2008
First Posted
July 23, 2008
Study Start
November 1, 2007
Primary Completion
April 1, 2010
Study Completion
September 1, 2010
Last Updated
December 23, 2011
Results First Posted
December 23, 2011
Record last verified: 2011-11